![Marten Steen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marten Steen
Direktor/Vorstandsmitglied bei
Healthneed AB
Profil
Marten Steen is currently a Director at Healthneed AB, Vivet Therapeutics SAS, Precirix NV, Aro Biotherapeutics Co., Priothera Ltd., Hemab ApS, Mahzi Therapeutics, Inc., and Managing Partner at HealthCap AB. He previously worked as an Independent Director at Ultragenyx Pharmaceutical, Inc., Director at Cortendo AB, Director at Merck Serono SA, Director at Altimmune UK Ltd., Director at Altimmune, Inc., Director at FerroKin BioSciences, Inc., Director at Modus Therapeutics AB, Director at Rainier Therapeutics, Inc., Independent Director at Wilson Therapeutics AB, Director at Glionova AB, Independent Director at Strongbridge Biopharma Plc, and Director at ADCendo ApS.
Dr. Steen obtained his undergraduate, graduate, and doctorate degrees from the University of Lund in 2005 and 2003 respectively.
Aktive Positionen von Marten Steen
| Unternehmen | Position | Beginn |
|---|---|---|
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Private Equity Investor | 01.04.2010 |
Healthneed AB | Direktor/Vorstandsmitglied | - |
Priothera Ltd.
 Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Direktor/Vorstandsmitglied | - |
Mahzi Therapeutics, Inc.
 Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Provides healthcare and biotechnology services | Direktor/Vorstandsmitglied | - |
Hemab ApS
 Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Direktor/Vorstandsmitglied | - |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Direktor/Vorstandsmitglied | - |
Vivet Therapeutics SAS
 Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Direktor/Vorstandsmitglied | - |
Precirix NV
 Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marten Steen
| Unternehmen | Position | Ende |
|---|---|---|
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Direktor/Vorstandsmitglied | 06.06.2017 |
| ░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Marten Steen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements. | Finance |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Pioneered cortisol inhibition as a treatment for Metabolic Syndrome | Commercial Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Health Technology |
Altimmune, Inc. /Old/
 Altimmune, Inc. /Old/ Medical/Nursing ServicesHealth Services Develops vaccines and other biological products | Health Services |
FerroKin BioSciences, Inc.
 FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drug for the treatment of severe malaria and sickle cell disease | Health Technology |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
Glionova AB
 Glionova AB BiotechnologyHealth Technology Develops cancer treatment drugs | Health Technology |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for rare diseases | Health Technology |
Healthneed AB | |
Vivet Therapeutics SAS
Vivet Therapeutics SAS BiotechnologyHealth Technology Operates as a clinical-stage emerging biotechnology company that develops novel gene therapy treatments for rare and inherited metabolic diseases | Health Technology |
Precirix NV
Precirix NV Pharmaceuticals: MajorHealth Technology Develops radiopharmaceuticals for cancer treatment | Health Technology |
ADCendo ApS
 ADCendo ApS BiotechnologyHealth Technology Operates as a clinical-stage biotech company that dedicated to developing transformative first and best-in-class antibody-drug conjugate therapies for cancers | Health Technology |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Priothera Ltd.
Priothera Ltd. Pharmaceuticals: MajorHealth Technology Develops hematological malignancies cells | Health Technology |
Hemab ApS
Hemab ApS BiotechnologyHealth Technology Develops antibodies for the treatment of rare bleeding disorders | Health Technology |
Mahzi Therapeutics, Inc.
Mahzi Therapeutics, Inc. BiotechnologyHealth Technology Provides healthcare and biotechnology services | Health Technology |
